| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $32,010,552 ) (Continued on the next page) |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32AG079666 | Molecular impact of endolysosomal dysfunction on neuron-glia communication pathways | 000 | 3 | NIH | 12/12/2024 | $22,289 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS124879 | Developmentally Programmed Remodeling of Apical ECM | 000 | 4 | NIH | 11/27/2024 | $393,522 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL150106 | Pericytes differentiate into smooth muscle cells through HIF2a/SDF1 activation | 000 | 5 | NIH | 12/13/2024 | $398,250 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | T2331594 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $1,176,446 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | T2331594 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $2,661,291 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F31NS141557 | Neuronal Primary Cilia Dysfunction in Tuberous Sclerosis Complex | 000 | 1 | NIH | 1/3/2025 | $45,132 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AI065617 | Genetic and Epigenetic Programming of Allergic Airway Inflammation | 000 | 24 | NIH | 12/30/2024 | $653,364 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21CA296527 | Advanced Genetic Engineering to Unravel Tumor-Specific B Cell Responses | 000 | 1 | NIH | 12/20/2024 | $249,645 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS129823 | Targeting the Choroid Plexus-Cerebrospinal Fluid System to Treat Post-Hemorrhagic Hydrocephalus | 000 | 3 | NIH | 12/16/2024 | $524,532 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS129823 | Targeting the Choroid Plexus-Cerebrospinal Fluid System to Treat Post-Hemorrhagic Hydrocephalus | 001 | 3 | NIH | 12/18/2024 | $94,333 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K23HD113884 | Social Risk Screening and Referral Implementation for All Pediatric Hospitals – The SOCIAL-H Study | 000 | 1 | NIH | 12/17/2024 | $159,848 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K23HD113884 | Social Risk Screening and Referral Implementation for All Pediatric Hospitals – The SOCIAL-H Study | 001 | 1 | NIH | 12/19/2024 | $0 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K23HD113884 | Social Risk Screening and Referral Implementation for All Pediatric Hospitals – The SOCIAL-H Study | 002 | 1 | NIH | 12/31/2024 | $75,000 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K99HL177326 | Unraveling Immune Cell Interactions and Multicellular Dynamics in GNAQ-Driven Capillary Malformation | 000 | 1 | NIH | 12/20/2024 | $127,305 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K23HD113884 | Social Risk Screening and Referral Implementation for All Pediatric Hospitals – The SOCIAL-H Study | 002 | 1 | NIH | 12/31/2024 | -$75,000 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01GM148392 | CD11c as a novel target to improve neutrophil effector functions and sepsis outcome | 000 | 3 | NIH | 12/20/2024 | $343,785 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL167925 | Simple and Effective Laceration of Potentially-calcified Leaflets as an Adjunct to Transcatheter Valve Replacement | 000 | 2 | NIH | 12/13/2024 | $718,215 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K23NS140397 | Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis | 000 | 1 | NIH | 12/16/2024 | $230,904 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K99DC022343 | Defining the role of MET components in vestibular hair cell maturation and gene therapy responsiveness | 000 | 1 | NIH | 12/17/2024 | $132,705 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01MH111647 | How do neurons in the brain decide to refine their synaptic connections in vivo? | 000 | 8 | NIH | 12/14/2024 | $739,143 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS121334 | Fetal Brain MRI as a Predictor of Late Neurodevelopmental Outcome in Congenital Heart Disease | 000 | 4 | NIH | 12/16/2024 | $426,716 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS121657 | Motion and Distortion Robust Diffusion Weighted Imaging Sequences for Pediatric Patients | 000 | 3 | NIH | 12/16/2024 | $398,250 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EY035684 | Kinase regulators of retinal ganglion cell survival and axon regeneration | 000 | 2 | NIH | 11/21/2024 | $628,760 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01MH137477 | Longitudinal EEG and Environmental Trajectories Leading to ADHD and Disruptive Behaviors from Infancy to Preschool | 000 | 1 | NIH | 11/22/2024 | $857,216 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DC008853 | Functional development of hair cells and neurons in the inner ear | 000 | 15 | NIH | 11/18/2024 | $475,716 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R37AI091476 | Therapeutic use of an enhanced form of CD4-Ig | 000 | 17 | NIH | 11/21/2024 | $884,356 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK124328 | Role of TAZ in metabolic regulation in both normal and insulin resistant states | 000 | 5 | NIH | 11/22/2024 | $406,311 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL171405 | Pericyte contribution to capillary remodeling in pulmonary arterial hypertension | 000 | 2 | NIH | 12/12/2024 | $718,270 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32HL172637 | Endothelial and mural cell interaction in capillary malformation | 000 | 2 | NIH | 12/5/2024 | $78,892 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K00NS120596 | The Development of Facial Motor Neuron Subtypes in Health and in Congenital Facial Weakness | 000 | 5 | NIH | 12/10/2024 | $96,281 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HD112379 | Metabolic control of the neural crest epigenome | 000 | 2 | NIH | 12/6/2024 | $504,496 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01ES034713 | Interdisciplinary approaches for understanding how arsenic and micronutrients affect the epigenome to influence spina bifida risk | 000 | 3 | NIH | 12/11/2024 | $763,305 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AR083424 | T peripheral regulatory cells as modulators of T cell-B cell interactions in arthritis | 000 | 2 | NIH | 12/11/2024 | $463,780 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DC017461 | Engineering multi-lineage inner ear organoids | 001 | 7 | NIH | 12/13/2024 | $68,687 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EB032708 | Fetal MRI: robust self-driving brain acquisition and body movement quantification | 000 | 4 | NIH | 11/26/2024 | $623,514 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R35NS105076 | Unravelling Mechanisms and Novel Therapeutic Targets for Peripheral Neuropathy and Neuropathic Pain | 000 | 8 | NIH | 11/29/2024 | $1,194,750 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R35NS105076 | Unravelling Mechanisms and Novel Therapeutic Targets for Peripheral Neuropathy and Neuropathic Pain | 001 | 8 | NIH | 12/26/2024 | $63,132 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS140165 | Use-Dependent Adjustments to Dopamine Reception in Motivational Control | 000 | 1 | NIH | 11/28/2024 | $529,878 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R37NS035129 | Human Epilepsy Genetics - Mosaic Mutations in Focal Epilepsy | 000 | 26 | NIH | 11/28/2024 | $910,212 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21AI178693 | Candida albicans Target of Rapamycin in oxidative stress responses | 000 | 1 | NIH | 11/22/2024 | $258,990 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K12HD052896 | Child Health Research Career Development Award (CHRCDA) Program (K12) | 000 | 18 | NIH | 11/29/2024 | $444,599 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32DK130267 | The role of TTC7A in apical lumen formation and polarized trafficking in the intestinal epithelium | 000 | 3 | NIH | 10/30/2024 | $87,064 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K01HL171354 | Associations between Perfluoroalkyl Substances (PFAS) Exposure and Aeroallergen Sensitization among Infants at High-Risk for Developing Asthma | 000 | 2 | NIH | 11/21/2024 | $161,316 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21EY035902 | Elucidating synaptic motifs in the visual thalamus | 000 | 2 | NIH | 11/21/2024 | $265,500 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL162367 | The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis | 000 | 4 | NIH | 11/7/2024 | $661,395 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32MD017452 | Sexual Minority Mental Health During the COVID-19 Pandemic: An Intersectional, Social Epidemiologic Investigation | 000 | 3 | NIH | 11/10/2024 | $78,784 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL161092 | Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes | 000 | 4 | NIH | 11/20/2024 | $624,822 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K99HL171947 | Novel role of Foxc2 in regulating metabolic disease | 000 | 2 | NIH | 11/8/2024 | $125,658 |
| | 2025 | 2025 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL155632 | Transcription Factor 4 Maintain Endothelial identity to Oppose Heart Failure | 000 | 4 | NIH | 11/19/2024 | $451,532 |
|
